[{"indications": "Indications\u00a0see under Dose", "name": "ATENOLOL With diuretic", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.4 Beta-adrenoceptor blocking drugs", "ATENOLOL", "With diuretic"], "cautions": "Cautions\u00a0see under Propranolol Hydrochloride", "side-effects": "Side-effects\u00a0see under Propranolol Hydrochloride", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2473.htm", "doses": ["By mouth, hypertension, 25\u201350\u00a0mg\r\ndaily (higher doses rarely necessary)", "Angina, 100\u00a0mg daily in 1 or 2 doses", "Arrhythmias, 50\u2013100\u00a0mg daily", "Migraine prophylaxis [unlicensed], 50\u2013200\u00a0mg daily in divided\r\ndoses", "By intravenous injection, arrhythmias,\r\n2.5\u00a0mg at a rate of 1\u00a0mg/minute, repeated at 5-minute intervals to\r\na max. of 10\u00a0mg", "Excessive bradycardia can be countered with intravenous injection of atropine sulphate 0.6\u20132.4\u00a0mg in divided doses of 600\u00a0micrograms; for overdosage see Emergency Treatment of Poisoning", "By intravenous infusion, arrhythmias,\r\n150\u00a0micrograms/kg over 20\u00a0minutes, repeated every 12 hours if required", "Early intervention within 12 hours of myocardial infarction\r\n(section 2.10.1), by intravenous injection over 5 minutes, 5\u00a0mg, then by mouth, 50\u00a0mg after\r\n15 minutes, 50\u00a0mg after 12 hours, then 100\u00a0mg daily", "Name[Kalten\u00ae (BPC 100) ] Capsules, red/ivory, atenolol 50\u00a0mg, amiloride hydrochloride 2.5\u00a0mg, hydrochlorothiazide 25\u00a0mg, net price 28-cap pack = \u00a312.17. \r\n    Label:\r\n    8Dose\u00a0hypertension, 1 capsule daily"], "pregnancy": "Pregnancy\u00a0\n(From 2.4 Beta-adrenoceptor blocking drugs: British National Formulary)\nPregnancy\u00a0Beta-blockers may cause intra-uterine growth restriction, neonatal hypoglycaemia, and bradycardia; the risk is greater in severe hypertension. The use of labetalol in maternal hypertension is not known to be harmful, except possibly in the first trimester. Information on the safety of carvedilol during pregnancy is lacking. If beta-blockers are used close to delivery, infants should be monitored for signs of beta-blockade (and alpha-blockade with labetalol or carvedilol). For the treatment of hypertension in pregnancy, see section 2.5."}]